Ferric Citrate Hydrate
Ferric Citrate Hydrate Uses, Dosage, Side Effects, Food Interaction and all others data.
Ferric Citrate Hydrate is an iron containing phosphate binder used to treat hyperphosphatemia and iron deficiency anemia in adults with chronic kidney disease.
Ferric Citrate Hydrate was granted FDA approval on 5 September 2014.
Ferric Citrate Hydrate is an iron containing product indicated to treat iron deficiency anemia and hyperphosphatemia. It has a wide therapeutic index, as doses can be varied significantly between patients. Ferric Citrate Hydrate has a long duration of action in the treatment of iron deficiency anemia, due to the slow loss of iron from the body, and a moderate duration of action in the treatment of hyperphosphatemia, due to its action being dependant on residence time in the gastrointestinal tract. Patients should be counselled regarding the risk of iron overload.
Trade Name | Ferric Citrate Hydrate |
Generic | Tetraferric tricitrate decahydrate |
Tetraferric tricitrate decahydrate Other Names | Ferric citrate, Ferric citrate hydrate |
Type | |
Formula | C18H32Fe4O31 |
Weight | Average: 967.803 Monoisotopic: 967.832498 |
Protein binding | Ferric iron is reduced to ferrous iron, which is carried by transferrin in serum. |
Groups | Approved |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Ferric citrate is a phosphate binder used to control serum phosphorus levels or as an iron supplement.
Ferric Citrate Hydrate is indicated to control serum phosphorous in adults with chronic kidney disease who require dialysis. Ferric Citrate Hydrate is also indicated to treat iron deficiency anemia in adults with chronic kidney disease who are not on dialysis.
Ferric Citrate Hydrate is also used to associated treatment for these conditions: Hyperphosphataemia, Iron Deficiency Anemia (IDA)
How Ferric Citrate Hydrate works
Ferric (Fe3+) iron is absorbed from the gastrointestinal tract by divalent metal transporter-1, and reduced to ferrous (Fe2+) iron by ferrireductase and cytochrome b reductase 1. Ferrous iron is stored intracellularly in ferritin and transported into the blood by ferroportin 1. Transport by ferroportin 1 is coupled with oxidation to ferric iron by hephaestin or ceruloplasmin. Ferric iron in plasma is bound to transferrin, which carries iron to other cells. Iron is transported to mitochondria for the synthesis of heme or iron-sulfur clusters, which are integral parts of several metalloproteins like hemoglobin.
Ferric iron can also bind to phosphate in the gastrointestinal tract, which precipitates as the insoluble ferric phosphate. Ferric phosphate remains unabsorbed and is eliminated in the feces. Decreased phosphate absorption gradually lowers phosphate levels in the blood.
Toxicity
Patients experiencing an overdose of iron may present with nausea, vomiting, abdominal pain, diarrhea, fluid and blood loss, hypovolemia, hematemesis, perforation, and peritonitis. Mild overdoses can be treated with symptomatic and supportive measures. More severe overdoses may require more intense treatment including chelating agents, and intravenous fluids. Activated charcoal is not expected to be beneficial in the case of iron overdose.
The acute oral LD50 in rats is 1487mg/kg and in mice is 1520mg/kg. The acute dermal LD50 in rabbits is 2000mg/kg.
Food Interaction
- Take with food.
Elimination Route
Ferric iron has been shown to have inferior bioavailability to ferrous iron preparations. Ferric Citrate Hydrate has 19% the bioavailability of ferrous ascorbate.
Clearance
Data regarding the clearance of iron is not readily available. However, iron loss due to exfoliation of epithelial cells is approximately 1mg/day.
Elimination Route
Unabsorbed oral Ferric Citrate Hydrate is eliminated in the feces. The absorbed iron from Ferric Citrate Hydrate is generally not eliminated from the body by any route other than blood loss and exfoliation of epithelial cells.
Innovators Monograph
You find simplified version here Ferric Citrate Hydrate